BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31666399)

  • 1. Multiple roles for HIV broadly neutralizing antibodies.
    Haynes BF; Burton DR; Mascola JR
    Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of broadly neutralizing antibodies for HIV prevention.
    Gelderblom HC; Corey L; Barouch DH
    J Int AIDS Soc; 2024 May; 27(5):e26257. PubMed ID: 38757844
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination.
    Mu Z; Haynes BF; Cain DW
    Curr Opin Virol; 2021 Dec; 51():172-178. PubMed ID: 34742037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine strategy for inducing broadly neutralizing antibodies against HIV.
    Marchal I
    Nat Biotechnol; 2024 Jun; 42(6):847. PubMed ID: 38886609
    [No Abstract]   [Full Text] [Related]  

  • 5. New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    Suran M
    JAMA; 2023 Feb; 329(7):527-528. PubMed ID: 36723948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.
    Ding C; Patel D; Ma Y; Mann JFS; Wu J; Gao Y
    Front Immunol; 2021; 12():697683. PubMed ID: 34354709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection.
    Muenchhoff M; Chung AW; Roider J; Dugast AS; Richardson S; Kløverpris H; Leslie A; Ndung'u T; Moore P; Alter G; Goulder PJR
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress on priming HIV-1 immunity.
    Sanders RW; Moore JP
    Science; 2024 May; 384(6697):738-739. PubMed ID: 38753801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target.
    Sherpa C; Le Grice SFJ
    Curr HIV Res; 2020; 18(2):114-131. PubMed ID: 32039686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination.
    Bekele Feyissa Y; Chiodi F; Sui Y; Berzofsky JA
    Front Immunol; 2021; 12():638872. PubMed ID: 33732259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo protection by broadly neutralizing HIV antibodies.
    van Gils MJ; Sanders RW
    Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
    Sadanand S; Suscovich TJ; Alter G
    Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadly Neutralizing Antibodies against HIV: Back to Blood.
    Dashti A; DeVico AL; Lewis GK; Sajadi MM
    Trends Mol Med; 2019 Mar; 25(3):228-240. PubMed ID: 30792120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in HIV vaccine development.
    Hsu DC; O'Connell RJ
    Hum Vaccin Immunother; 2017 May; 13(5):1018-1030. PubMed ID: 28281871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic HIV vaccines and broadly neutralizing antibodies.
    Sobieszczyk ME
    Top Antivir Med; 2020 Jan; 27(4):97-101. PubMed ID: 32224500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly neutralizing antibodies: "The next thing" to treat children with HIV?
    Mavigner M; Chahroudi A
    Sci Transl Med; 2023 Jul; 15(703):eadi0293. PubMed ID: 37406135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies.
    Bharadwaj P; Riekofski C; Lin S; Seaman MS; Garber DA; Montefiori D; Sarzotti-Kelsoe M; Ackerman ME; Weiner JA
    J Immunol Methods; 2020 Apr; 479():112764. PubMed ID: 32070674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.
    Huang D; Tran JT; Olson A; Vollbrecht T; Tenuta M; Guryleva MV; Fuller RP; Schiffner T; Abadejos JR; Couvrette L; Blane TR; Saye K; Li W; Landais E; Gonzalez-Martin A; Schief W; Murrell B; Burton DR; Nemazee D; Voss JE
    Nat Commun; 2020 Nov; 11(1):5850. PubMed ID: 33203876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Vaccines: One Step Closer.
    Low MSY; Tarlinton D
    Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triggering rare HIV antibodies by vaccination.
    Moore PL
    Science; 2022 Dec; 378(6623):949-950. PubMed ID: 36454831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.